Codexis, Inc.

NASDAQ:CDXS

Biotechnology

Healthcare
$1.15 +0.60%

+$0.02 today

Market cap
$126.04M
Beta
2.48
P/E (TTM)
-7.1
EPS (TTM)
-$0.35
52W Low $0.96High $3.87

Volume 1.47M

Average 1.15M

Returns on capital

Codexis, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-87.0%

avg -47.7%

ROIC

-30.6%

avg -31.8%

ROA

-29.8%

avg -24.4%

Analysis

ROA is currently the strongest return metric at -29.8% versus its period average of -24.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Alison Moore

President, Chief Executive Officer & DirectorUSD 1M59244.17K0.27%

Georgia L. Erbez

Chief Financial Officer & Chief Business OfficerUSD 745.96K59——

Stefan Lutz

Chief Scientific OfficerUSD 729.16K—130.42K0.14%

John Schiffhauer

Senior Vice President of Intellectual Property————

Karen Frechou-Armijo

Senior Vice President & Head of Human Resources————

Britton Jimenez

Senior Vice President of Sales & Marketing————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 12, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

1

$258,266.13

Sells

16

$944,304.93

Net Transaction Value

−$686,038.79

Net selling

Most Active

Opaleye Management Inc.

7 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 9, 26

De Vre Raymond

Direct

Sell$1.2K
Oct 12, 26

Erbez Georgia

Direct

Sell$8.6K
Oct 12, 26

MOORE ALISON

Direct

Sell$8.6K
Jun 11, 26

De Vre Raymond

Direct

Sell$6.2K
Feb 24, 26

Lutz Stefan

Direct

Sell$6.6K
Feb 6, 26

Lutz Stefan

Direct

Sell$3.3K
Feb 6, 26

Erbez Georgia

Direct

Sell$5K
Feb 6, 26

MOORE ALISON

Direct

Sell$5K
Jan 7, 26

Lutz Stefan

Direct

Sell$7.9K
Dec 1, 25

Opaleye Management Inc.

Indirect

Sell$14.2K

1–10 of 17

Summary

Insiders reported 1 buys worth $258,266.13 and 16 sells worth $944,304.93 over the last 12 months. That adds up to net selling of $686,038.79. Opaleye Management Inc. was the most active insider with 7 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-20.2%
+19.1% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at -20.2% over three years. Forward estimates point to Revenue at +19.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Codexis, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CDXS's management, answered from reported figures.

Who manages CDXS?

Codexis, Inc. (CDXS) lists 6 active executives. The top listed executive is John Schiffhauer, Senior Vice President of Intellectual Property.

Are CDXS insiders buying or selling?

Recent insider activity shows net buying of $31.36M.